The QVue app has you covered
- Test seamlessly
- Animated steps guide you through the testing process
- Animated steps guide you through the testing process
- Share results
- Easily share your results with anyone, anytime, directly from the app
- Easily share your results with anyone, anytime, directly from the app
- Access results
- Save test results for you and your family, making them accessible and shareable whenever needed
Optimize your testing experience
Test with confidence
Get the QVue app and have everything you need for your best testing experience
Disclaimer: The QVue app is supported on iOS 13 or newer for Apple iPhones and Android 9 or newer for Android Phones.
App Store and the Apple Logo are trademarks of Apple Inc.
Google Play and the Google Play Logo are trademarks of Google LLC.
QVue app general FAQs
The QVue app is not required to take your QuickVue COVID-19 Test, but it can make your testing experience less stressful and increase confidence in your result. The app provides clear, visual, step-by-step instructions from opening your test through result interpretation, taking the guesswork out of testing and helping ensure your test and results are valid.
By completing your test with the QVue app, you can easily access a history of results for you and your family from a single place and share a record of your results with whomever, whenever you want. For new and experienced testers, the QVue app provides an easy and stress-free way to test for COVID-19.
QVue makes it convenient and super easy to share a record of your result to whomever, whenever you want. Select the “Test Result” tab on the menu, choose the user, and then select the specific result from your history that you want to share. It’s as easy as sharing a photo with a friend. Select “Share,” then choose who you want to send it to and how—text, e-mail, or another app enabled on your phone.
Share your test results with public health authorities
Prevent the spread of COVID-19 and support contact-tracing efforts by reporting your results.
Our QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test.
The QuickVue COVID-19 Test is a visually read lateral flow immunoassay device intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal (nares) swab specimens from individuals with signs and symptoms of COVID-19 within the first 5 days from symptom onset. This test is for non-prescription home use by individuals aged 14 years or older testing themselves, or adults testing individuals aged 2 years or older.
The QuickVue COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2.
All negative results are presumptive. Symptomatic individuals with an initial negative test result must be re-tested once between 48 and 72 hours after the first test using either an antigen test or a molecular test for SARS-CoV-2. Negative results do not preclude SARS-CoV-2 infections or other pathogens and should not be used as the sole basis for treatment. Positive results do not rule out co-infection with other respiratory pathogens.
This test is not a substitute for visits to a healthcare provider or appropriate follow-up and should not be used to determine any treatments without provider supervision. Individuals who test negative and experience continued or worsening COVID-19 like symptoms, such as fever, cough and/or shortness of breath, should seek follow up care from their healthcare provider.
The performance characteristics for SARS-CoV-2 were established from January 2021 to February 2024 when COVID-19 variants Alpha, Delta, and Omicron were dominant. Test accuracy may change as new SARS-CoV-2 viruses emerge. Additional testing with a lab-based molecular test (e.g., PCR) should be considered in situations where a new virus or variant is suspected.
